Xianghe Capital is a venture capital fund focusing on early and growth stage investments in TMT industry in China.
Founded by Mr. Hesong Tang and Ms. Maggie Yang, Xiang He Capital is a venture capital fund focusing on early and growth stage investments in TMT industry in China. Before starting Xiang He, Mr. Tang was Baidu's VP of Corporate Development, overseeing strategic investments and M&A, and Ms. Yang was Baidu's Managing Director of Corporate Development. They have led a series of landscape-changing deals such as iQiyi, Qunar, PPS and 91 wireless, which all have a significant impact on China's TMT industry.Xiang He's team have a background from Corporate Development of Baidu, other leading internet companies, and VC funds. The team is particularly strong in strategic analysis and has deep connections in the internet industry. Xiang He's investments are driven by strategic analysis and collective wisdom.
Date
Company Name
|
Round | Money Raised | Industry | Lead Investor |
---|---|---|---|---|
Jan 27, 2022
Ractigen Therapeutics
|
Series A | $30M | Health Care | — |
Jun 29, 2020
Zuoyebang
|
Series E | $750M | Apps | — |
Nov 8, 2018
Synyi
|
Series B | $20.20M | Artificial Intelligence | Yes |
Aug 14, 2017
Zuoyebang
|
Series C | $150M | Apps | — |
Sep 25, 2016
Zuoyebang
|
Series B | $60M | Apps | Yes |